Management of immune thrombocytopenic purpura (ITP/PTI) involves a staged approach, utilizing corticosteroids and intravenous immunoglobulins as first-line treatment. Second-line therapies, including TPO-receptor agonists and splenectomy, are employed for refractory cases. For detailed, downloadable clinical guidelines and studies, you can access documents on ResearchGate and ScienceDirect .

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Purpura rhumatoïde et immunoglobulines intraveineuses